Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy): An article from: Skin & Allergy News
Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy): An article from: Skin & Allergy News: : This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2003. The length of the article is 726 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy)
Author: Diana Mahoney
Publication:Skin & Allergy News (Magazine/Journal)
Date: August 1, 2003
Publisher: International Medical News Group
Volume: 34 Issue: 8 Page: 35(1)
Article Type: Product/Service Evaluation
Distributed by Thomson Gale
Cheap Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy): An article from: Skin & Allergy News : Buy Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy): An article from: Skin & Allergy News : Free Shipping Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy): An article from: Skin & Allergy News : Best Price For Efavirenz vs. nevirapine for HIV trial inconclusive: head-to-head trial a draw.(Dermatoligic Theraphy): An article from: Skin & Allergy News : read more.
Tags : Aikido Techniques Aikitaiso The Price for The Original Broadway Cast 6 Ideas For Painting